Globe Biomedical specializes the commercialization of novel systems for mechanical and biomedical measurements with a focus area in large strain monitoring. Globe Biomedical was formed with the specific purpose of developing and commercializing novel, wearable technology created through innovative biomedical research in the Gordon and Jill Bourns College of Engineering at California Baptist University in Riverside, California. Initial funding for development of the technology, which holds great promise as a non-invasive tool for monitoring glaucoma therapies, was awarded to Globe Biomedical through America’s Seed Fund, the SBIR program of the National Science Foundation (NSF). See the News section of www.cureframes.com to follow Globe on their path to bringing the technology to patients.
Globe is committed to efficiently executing the research and development of cutting edge technologies. Globe is bringing practical, innovative solutions to our customers and fostering economic development and creativity in the Inland Empire. In addition to Cure™ Frames, Globe’s commercialization pipeline includes continuous implantable sensors for monitoring intraocular pressure (IOP), kiosk-type and at-home image-based IOP monitors, discrete resistor strain sensors for monitoring mechanical systems, and mobile app technologies for real-time access and data management of medical and mechanical monitoring systems. Globe’s extensive technical expertise, combined with years of experience bringing products to market, provide the company with capabilities to improve the lives of patients and customers around the globe.
Or use our contact form.